Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
4 March 2011

IN THIS ISSUE
Sanofi cGMP violations
EU-India FTA
EMA conflict of interests
Rare diseases day

 
Sanofi-aventis receives FDA warning letters
The FDA has sent Sanofi-aventis a warning letter describing violations of cGMP regulations that the agency observed during an inspection of a facility in Germany. More...
 
EU–India FTA dispute continues
Ongoing Free Trade Agreement (FTA) negotiations between the EU and India have hit a hurdle as some stakeholders urge the Indian government to fight against certain provisions in the FTA amid fears that access to generic drugs may be affected. More...
 
EMA challenged over conflict of interest case
A number of European public health and transparency campaigners believe that conflict of interest rules may have been breached with the EMA’s decision to allow its former Executive Director, Thomas Lönngren, to take up an advisory role within the private pharmaceutical sector. More...
 
Rare Disease Day 2011 – "Rare but Equal"
The European Organisation for Rare Diseases (EURORDIS), an alliance of patient organizations and individuals, celebrated its fourth Rare Disease Day on February 28. More...
 
Merck sells contract biopharm business to Fujifilm
Fujifilm and Merck & Co. have formed a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a contract biopharmaceutical manufacturing and development business of Merck. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Confusing language and a dubious victory for patients
Sanofi-aventis to acquire Genzyme for $20.1 billion
Re-inventing R&D
More blog posts

Latest peer-reviewed research
Characterizing a nasal spray formulation from droplet to API particle size
Printable medicines: a microdosing device for producing personalized medicines
An initial report of CDER's recall root cause research project (Part II)
More articles

Upcoming events
MEDTEC Europe (22–24 March | Germany)
Pharma Packaging and Labelling Compliance Conference (23–25 March | Spain)
IVT’s 2nd Annual Validation Week EU (28–30 March | The Netherlands)
More events

Product Profiles
Oxoid

Harmonized Culture Media for MLT
Oxoid and Remel, the world leading microbiology brands of Thermo Fisher Scientific, have introduced a complete portfolio of culture media for the microbiological examination of non sterile pharmaceutical products, as recommended in the Harmonized Microbial Limit Tests chapters in the Ph. Eur, USP and JP (current editions). Read more...

 
Sterilin

High quality pharmaceutical packaging products
Sterilin high quality plastic packaging products are ideal for storing and transporting a wide range of pharmaceutical products. Read more...


Recruitment Profile
 
placeholder

Vacancy notice for a selection procedure open to nationals of Council of Europe member states

Head of the Publications and Multimedia Department Vacancy notice: e45/2011. Read more...

 

 

 


Survey
From which region do you buy the majority of your tablet manufacturing equipment?
Asia 43%
 
Europe 34%
     
US 19%
     
Other 4%

This week we would like to know...

Has the FDA's transparency initiative helped your company?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH